These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24051205)

  • 41. Toll-like receptor recognition of Toxoplasma gondii.
    Yarovinsky F; Sher A
    Int J Parasitol; 2006 Mar; 36(3):255-9. PubMed ID: 16476433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and function of Toll-like receptors in T lymphocytes.
    Kabelitz D
    Curr Opin Immunol; 2007 Feb; 19(1):39-45. PubMed ID: 17129718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Signal transduction pathways mediated by Toll-like receptors and their relations with fungal keratitis].
    Chen P; Xie LX
    Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):80-4. PubMed ID: 22490919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.
    Muzio M; Scielzo C; Bertilaccio MT; Frenquelli M; Ghia P; Caligaris-Cappio F
    Br J Haematol; 2009 Feb; 144(4):507-16. PubMed ID: 19036098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Toll-like receptors expression on Burkitt lymphoma cells].
    Siennicka J; Trzcińska A; Cześcik A; Dunal M
    Med Dosw Mikrobiol; 2011; 63(4):349-54. PubMed ID: 22384669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Toll-like receptors' two-edged sword: when immunity meets apoptosis.
    Salaun B; Romero P; Lebecque S
    Eur J Immunol; 2007 Dec; 37(12):3311-8. PubMed ID: 18034428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic targeting of Toll-like receptors in cutaneous disorders.
    Matin N; Tabatabaie O; Mohammadinejad P; Rezaei N
    Expert Opin Ther Targets; 2015; 19(12):1651-63. PubMed ID: 26189326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenotypic and functional characterization of human malignant T cells.
    Harden EA; Haynes BF
    Semin Hematol; 1985 Jan; 22(1):13-26. PubMed ID: 3918348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
    Huber H; Gattringer C; Thaler J; Peschel C
    Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toll-like receptors and control of mycobacterial infection in mice.
    Ryffel B; Jacobs M; Parida S; Botha T; Togbe D; Quesniaux V
    Novartis Found Symp; 2006; 279():127-39; discussion 139-41, 216-9. PubMed ID: 17278391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of innate immune responses by Toll-like receptors.
    Takeda K; Akira S
    Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of adaptive immunity with Toll-like receptors.
    Manicassamy S; Pulendran B
    Semin Immunol; 2009 Aug; 21(4):185-93. PubMed ID: 19502082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Innate immunity to mycobacterial infection in mice: critical role for toll-like receptors.
    Ryffel B; Fremond C; Jacobs M; Parida S; Botha T; Schnyder B; Quesniaux V
    Tuberculosis (Edinb); 2005; 85(5-6):395-405. PubMed ID: 16257265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coupling pathogen recognition to innate immunity through glycan-dependent mechanisms.
    Davicino RC; Eliçabe RJ; Di Genaro MS; Rabinovich GA
    Int Immunopharmacol; 2011 Oct; 11(10):1457-63. PubMed ID: 21600310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluating the role of Toll-like receptors in diseases of the central nervous system.
    Carty M; Bowie AG
    Biochem Pharmacol; 2011 Apr; 81(7):825-37. PubMed ID: 21241665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders.
    Goldman M
    Clin Exp Immunol; 2007 Feb; 147(2):208-16. PubMed ID: 17223960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression and function of toll-like receptors in multiple myeloma patients: toll-like receptor ligands promote multiple myeloma cell growth and survival via activation of nuclear factor-kappaB.
    Xu Y; Zhao Y; Huang H; Chen G; Wu X; Wang Y; Chang W; Zhu Z; Feng Y; Wu D
    Br J Haematol; 2010 Sep; 150(5):543-53. PubMed ID: 20629663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Toll-like receptors: recognition receptors of the innate immune system and target structures for therapeutical intervention].
    Kabelitz D
    Med Monatsschr Pharm; 2012 Jul; 35(7):238-44. PubMed ID: 22852274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of haematological malignancies and their treatment on host defence factors.
    Hersh EV; Gutterman JU; Mavligit GM
    Clin Haematol; 1976 Jun; 5(2):425-48. PubMed ID: 780032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dissecting negative regulation of Toll-like receptor signaling.
    Kondo T; Kawai T; Akira S
    Trends Immunol; 2012 Sep; 33(9):449-58. PubMed ID: 22721918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.